People

The People Running Copart

Governance grade: B+. Two owner-operators with billions of personal stock at stake run this company, the named CEO pays himself like a manager (not an owner), and the board is genuinely independent on committees — but the board's September 2025 decision to let founder Willis Johnson pledge up to 20% of his shares against personal loans is the one real blemish on what is otherwise an exceptionally aligned ownership structure.

The People Running This Company

Three executives matter. Two of them are still here mostly because they own the place.

Founder + son-in-law control roughly 8.9% of the company outright — a combined position worth about $3.0B at the share count and recent price implied by Form 4 sales near $40–47. Johnson built this business over four decades; Adair ran it for twelve years and then handed the keys to Liaw in 2024 without leaving the room. The succession from founder → son-in-law → professional hire is unusually orderly for a US large-cap and looks like it was planned for years.

Liaw is the working CEO. He came up through the CFO seat, ran North America, then was Co-CEO before getting sole title in April 2024. His ownership is small relative to the founders but his option position is large — 3.05M options exercisable within 60 days of October 2025 at strikes mostly under $11 (versus a recent stock price in the mid-$40s).

Stearns is the newest face — joined as CFO in December 2022 with an oversized onboarding equity package. Her FY2025 cash bonus paid 99.4% of target, suggesting committees see her as performing.

What They Get Paid

CEO Liaw's $2.07M total pay is unusually modest for a company that produced $1.55B of net income on $4.65B of revenue. The 46-to-1 pay ratio versus the median employee is roughly one-fifth of the S&P 500 large-cap norm. Adair's "compensation" is essentially personal aircraft use ($349,638) and a company car — disclosed perks that look enormous in dollars but are tiny relative to his ~$1.0B stake.

The catch is what is not in the FY2025 table. Liaw's 3.05M of exercisable options at sub-$11 strikes are worth roughly $100M+ in intrinsic value at recent prices. He is being paid like a manager on the income statement and like a founder on the cap table. Stearns's FY2023 onboarding award ($9.7M total, mostly options struck near $61) does the same job in smaller scale.

Are They Aligned?

Ownership and control

The control story is simple: the founder and his son-in-law together hold 8.9% of the company, more than any index fund. There is no dual-class structure, no super-voting stock, no shareholder rights plan — they simply own a lot. Combined insider/director ownership at 9.6% of float is unusually high for a large-cap and dwarfs the typical S&P-500 CEO's 0.1-0.2% holding.

Insider buying vs. selling (last 18 months)

What looks like heavy selling is almost entirely option-exercise-and-sell: every dollar in the "sold" column was paired with a same-day exercise at $4.91 / $6.78 / $8.70 / $11.80 strikes set 5-7 years ago. None of it is open-market dumping of pre-existing stock. The CEO's net cash-realized of ~$2.4M is small relative to his retained option book. The two founders sold zero shares of pre-existing stock; Adair's only dispositions were gifts to charitable trusts.

That said, the directors are aggressively monetizing as their old option tranches mature — Englander and Tryforos each cashed over $12M in 18 months. None of them bought a single share on the open market. This is normal large-cap director behavior but it is not a vote of conviction.

Dilution and equity grants

The Compensation Committee has not granted Liaw any equity for three consecutive fiscal years. Stearns received nothing in FY2025. Director awards continue at $250k/year in options. Net dilution at the insider level over the past year is light — most "issuance" is just old option vesting and exercise. There is no chronic SBC creep here.

Related-party transactions

Two family members on payroll at meaningful (but not outrageous) compensation is typical owner-operator hygiene. Both are disclosed and Audit-Committee reviewed.

The Johnson pledging waiver is the live concern. The anti-pledging policy exists precisely because pledged shares can be force-sold in a margin event, depressing the stock for everyone else. Approving an exception for a 5.75% holder — up to 20% of his stake, roughly 11M shares — is the kind of accommodation a fully independent board would push back on.

Skin-in-the-game score

We score this 8 out of 10. The two founders hold roughly $3B of equity between them with no diversification mechanism, the working CEO has refused equity grants for four years and still has nine-figure option intrinsic value, the CFO had to put up onboarding shares to get the job, and there is no dual-class lever protecting management against shareholders. The penalty against a perfect score is the pledging waiver plus light director selling that signals "we like the price here."

Board Quality

The board has 12 directors, 9 of them independent under Nasdaq rules. All three standing committees are 100% independent on paper. The structural box is checked.

What is harder to check is whether independence is real. Lead Independent Director Steven Cohan was a Copart officer 1992-1996 and has been on the board since 2004 — 21 years of relationship with the founders, including his prior employment. Englander (~18 years) and Tryforos (~16 years) also have extremely long tenures. Long-tenured "independent" directors are usually friends of the founder by the end. None of them voted against management on any disclosed matter; say-on-pay carried with ~95% support in 2024.

The encouraging signs are the relatively recent additions — Morefield (Audit Chair), Sparks, LeBon, Fisher, Blunt — who bring legal, finance, and consumer-marketing expertise without legacy ties. The Audit Chair (Morefield) and Comp Chair (Englander) are both bona fide outsiders by background.

The Verdict

Grade: B+.

The positives are the kind that matter to long-term holders: founders with nine-figure unsold stakes, a working CEO paid like a steward and incentivized like a founder, no dual-class structure, a clean clawback policy, no hedging, light SBC, and an audit committee actually staffed by people with finance backgrounds.

The concerns are the kind that hint at how much room shareholders have if something goes wrong: a board that has spent two decades with the same founder voices, a Lead Independent Director who used to work for the company, and a fresh pledging waiver that exists for the founder's benefit, not for any business reason.

Most likely path to a downgrade: further accommodations to the founder family that look like the pledging waiver — additional related-party employment, perquisites that grow faster than performance, or an expansion of the pledging right beyond 20%.

Most likely path to an upgrade: the Compensation Committee's FY2026 grant to Liaw. A modest, performance-vested grant on his April 2026 eligibility date would signal that the committee can independently decide what the working CEO is worth. A blowout package — or a do-nothing renewal of the "$900k salary, no equity" pattern — would extend the current B+.